Analysis

GlaxoSmithKline sets sights on mid-century carbon neutrality

Drug company GlaxoSmithKilne has committed to becoming carbon neutral by 2050. It has already cut emissions by 4% over the past three years, but questions remain over how it will achieve its goal.

Sorry you do not have access to this article. Please contact Customer Support at
report@ends.co.uk
or call 020 8267 8120